Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATT NYSE:BPT TSE:CGI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/ABPTBP Prudhoe Bay Royalty Trust$0.50$0.57$0.49▼$0.79N/AN/AN/AN/ACGICanadian General InvestmentsC$51.35C$49.43C$35.80▼C$52.97C$1.07B0.9942333,990 shs2,212 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%BPTBP Prudhoe Bay Royalty Trust0.00%0.00%0.00%0.00%-20.19%CGICanadian General Investments0.00%-1.61%-1.25%+4.50%+42.05%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/ABPTBP Prudhoe Bay Royalty Trust$0.50$0.57$0.49▼$0.79N/AN/AN/AN/ACGICanadian General InvestmentsC$51.35C$49.43C$35.80▼C$52.97C$1.07B0.9942333,990 shs2,212 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%BPTBP Prudhoe Bay Royalty Trust0.00%0.00%0.00%0.00%-20.19%CGICanadian General Investments0.00%-1.61%-1.25%+4.50%+42.05%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/ABPTBP Prudhoe Bay Royalty Trust 0.00N/AN/AN/ACGICanadian General Investments 0.00N/AC$175.00240.80% UpsideCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/ABPTBP Prudhoe Bay Royalty Trust$6.64M1.62N/AN/A$0.17 per share2.95CGICanadian General InvestmentsC$266.55M4.02C$76.45 per share0.67C$80.66 per share0.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AN/ABPTBP Prudhoe Bay Royalty Trust-$1.14MN/AN/AN/AN/AN/AN/AN/AN/ACGICanadian General InvestmentsC$164.46MC$12.424.13N/AN/A213.97%16.45%8.12%N/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/ABPTBP Prudhoe Bay Royalty Trust$0.2345.82%N/AN/AN/ACGICanadian General InvestmentsC$1.082.10%N/A8.70%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATTAbattis BioceuticalsN/AN/AN/ABPTBP Prudhoe Bay Royalty TrustN/AN/AN/ACGICanadian General Investments11.899.427.44Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/ABPTBP Prudhoe Bay Royalty Trust5.66%CGICanadian General Investments0.22%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/ABPTBP Prudhoe Bay Royalty TrustN/ACGICanadian General Investments16.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableBPTBP Prudhoe Bay Royalty Trust2,02021.40 millionN/ANo DataCGICanadian General InvestmentsN/A20.86 millionN/ANot OptionableCGI, BPT, ATT, and HVPE HeadlinesRecent News About These CompaniesCanadian General Investments (TSE:CGI) Hits New 12-Month High - Time to Buy?May 11, 2026 | marketbeat.comCanadian General Investments (TSE:CGI) Reaches New 52-Week High - Here's WhyApril 23, 2026 | marketbeat.comCanadian General Investments Files 2025 Interim ReportAugust 15, 2025 | msn.comCanadian General Investments (TSE:CGI) Director Clive William Robinson Buys 1,000 SharesJuly 30, 2025 | insidertrades.com(CGI) Optimized Trading OpportunitiesFebruary 7, 2025 | news.stocktradersdaily.comNCanadian General Investments Ord (CGI.TO)January 21, 2025 | finance.yahoo.comCanadian General Investments, Limited (CGRIF)November 23, 2024 | finance.yahoo.comI'm a fund manager: Greg Eckel of Canadian General Investments on where he would investNovember 13, 2024 | thisismoney.co.ukTCGI Reports Rise in 4Q Earnings, RevenueNovember 6, 2024 | marketwatch.comShould you invest in Canada?October 22, 2024 | moneyweek.comMCanadian Fintechs Secure Record $7.8 Billion in Funding in H1 2024 – Research ReportAugust 8, 2024 | crowdfundinsider.comCCGI Taps Francois Boulanger as Next CEOMay 22, 2024 | marketwatch.comCGI Inc.'s (TSE:GIB.A) Intrinsic Value Is Potentially 45% Above Its Share PriceMay 22, 2024 | finance.yahoo.comTactical Woodside vote a metaphor for Australia’s low-carbon transitionApril 26, 2024 | afr.comPrice pressures easing ‘substantially’ as profits jump, says TescoApril 10, 2024 | msn.comCanadian General Investments, Limited Files Annual Disclosure DocumentsMarch 13, 2024 | finance.yahoo.comCGI to Buy C$250M Shares Held by Executive Chairman Serge GodinFebruary 23, 2024 | marketwatch.comAsia-Pacific Surgical Robotics Market Forecast Report: Estimates for 2023, & Forecasts 2024-2032January 31, 2024 | finance.yahoo.comToronto Stocks Slide, Canada GDP Rises, CGI Shares Rise on 1Q Beats and BuybacksJanuary 31, 2024 | marketwatch.comCanadian General Investments, Limited Announces Additional Independent DirectorsNovember 15, 2023 | finance.yahoo.comCanadian General Investments: Portfolio UpdateNovember 4, 2023 | cbonds.comCNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesHow the 3 Leading Quantum Firms Stack Up After Q1 EarningsBy Nathan Reiff | May 14, 2026Apple’s Earnings Make $300 Look Like a Matter of When, Not IfBy Sam Quirke | May 1, 2026Why Lockheed Martin's Earnings Miss Could Be a Blessing in DisguiseBy Sam Quirke | May 4, 2026Tesla’s Earnings Confirm the Shift to AI—But at What Cost?By Sam Quirke | April 23, 2026Big Bank Earnings Gave Financials a Lift, But Wall Street Is Still CautiousBy Jessica Mitacek | April 22, 2026CGI, BPT, ATT, and HVPE Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.BP Prudhoe Bay Royalty Trust NYSE:BPTBP Prudhoe Bay Royalty Trust operates as a grantor trust in the United States. It is involved in holding overriding royalty interest in the Prudhoe Bay oil field located on the North Slope of Alaska. The Prudhoe Bay field extends approximately 12 miles by 27 miles and contains approximately 150,000 gross productive acres. BP Prudhoe Bay Royalty Trust was incorporated in 1989 and is based in Houston, Texas.Canadian General Investments TSE:CGIC$51.35 0.00 (0.00%) As of 05/15/2026 11:50 AM EasternA closed-end equity fund focused on medium to long-term capital appreciation and dividends in Canadian corporations. The Manager utilizes a bottom-up investment strategy in an effort to achieve the Corporations investment objectives. With this type of investment strategy, the Manager first seeks individual companies with attractive investment potential, then proceeds to consider the larger industry, economic and global trends affecting those companies. The Manager attempts to mitigate market risk by maintaining a well-diversified portfolio of primarily publicly-listed Canadian equities with individual positions generally not exceeding 5 percent of the total investment portfolio. Foreign securities are typically not expected to exceed 15 Percent, in aggregate, of the portfolios market value. Derivatives may not be used by the Manager to achieve the Corporations investment objectives. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Peloton Stock Gives Back Gains After Upbeat Earnings Report MarketBeat Week in Review – 05/11 - 05/15 Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Alphabet's Googlebook Brings Gemini AI to PC Hardware As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In Robinhood, SoFi, and Webull Are Telling Very Different Stories Viking Sails to All-Time Highs—Fundamentals Signal More to Come Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
